97 related articles for article (PubMed ID: 26112935)
21. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells.
Gryparis EC; Hatziapostolou M; Papadimitriou E; Avgoustakis K
Eur J Pharm Biopharm; 2007 Aug; 67(1):1-8. PubMed ID: 17303395
[TBL] [Abstract][Full Text] [Related]
22. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
Shi Y; Goodisman J; Dabrowiak JC
Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
[TBL] [Abstract][Full Text] [Related]
24. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
25. Gold Nanoparticles Biosynthesized and Functionalized Using a Hydroxylated Tetraterpenoid Trigger Gene Expression Changes and Apoptosis in Cancer Cells.
Tian B; Li J; Pang R; Dai S; Li T; Weng Y; Jin Y; Hua Y
ACS Appl Mater Interfaces; 2018 Oct; 10(43):37353-37363. PubMed ID: 30295457
[TBL] [Abstract][Full Text] [Related]
26. Covalent assembly of gold nanoparticles for nonvolatile memory applications.
Gupta RK; Kusuma DY; Lee PS; Srinivasan MP
ACS Appl Mater Interfaces; 2011 Dec; 3(12):4619-25. PubMed ID: 22023018
[TBL] [Abstract][Full Text] [Related]
27. Green chemistry approach for the synthesis and stabilization of biocompatible gold nanoparticles and their potential applications in cancer therapy.
Mukherjee S; Sushma V; Patra S; Barui AK; Bhadra MP; Sreedhar B; Patra CR
Nanotechnology; 2012 Nov; 23(45):455103. PubMed ID: 23064012
[TBL] [Abstract][Full Text] [Related]
28. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment.
Ma X; Wu Y; Jin S; Tian Y; Zhang X; Zhao Y; Yu L; Liang XJ
ACS Nano; 2011 Nov; 5(11):8629-39. PubMed ID: 21974862
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress contributes to gold nanoparticle-induced cytotoxicity in human tumor cells.
Mateo D; Morales P; Ávalos A; Haza AI
Toxicol Mech Methods; 2014 Mar; 24(3):161-72. PubMed ID: 24274460
[TBL] [Abstract][Full Text] [Related]
30. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
31. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
32. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.
Cheng Y; Samia AC; Li J; Kenney ME; Resnick A; Burda C
Langmuir; 2010 Feb; 26(4):2248-55. PubMed ID: 19719162
[TBL] [Abstract][Full Text] [Related]
33. Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5alpha-reductase inhibitor.
Sutkowski DM; Audia JE; Goode RL; Hsiao KC; Leibovitch IY; McNulty AM; Neubauer BL
Prostate Suppl; 1996; 6():62-6. PubMed ID: 8630232
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic investigations, antimicrobial, and cytotoxic activity of green synthesized gold nanoparticles.
Lokina S; Suresh R; Giribabu K; Stephen A; Lakshmi Sundaram R; Narayanan V
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():484-90. PubMed ID: 24755638
[TBL] [Abstract][Full Text] [Related]
35. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of glycopolymeric decorated gold nanoparticles functionalized with gold-triphenyl phosphine as anti-cancer agents.
Adokoh CK; Quan S; Hitt M; Darkwa J; Kumar P; Narain R
Biomacromolecules; 2014 Oct; 15(10):3802-10. PubMed ID: 25162942
[TBL] [Abstract][Full Text] [Related]
37. Effect of HUVEC apoptosis inducing proteinase from Vipera lebetina venom (VLAIP) on viability of cancer cells and on platelet aggregation.
Samel M; Trummal K; Siigur E; Siigur J
Toxicon; 2012 Sep; 60(4):648-55. PubMed ID: 22781133
[TBL] [Abstract][Full Text] [Related]
38. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-functionalized polymer platform for controlling metastatic cancer cell adhesion, shape, and motility.
Lee H; Jang Y; Seo J; Nam JM; Char K
ACS Nano; 2011 Jul; 5(7):5444-56. PubMed ID: 21702475
[TBL] [Abstract][Full Text] [Related]
40. Biological response of hydrogels embedding gold nanoparticles.
Marsich E; Travan A; Donati I; Di Luca A; Benincasa M; Crosera M; Paoletti S
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):331-9. PubMed ID: 21186099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
